Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
Xuerong Wang(Anhui Medical University), Shi‐Yong Sun(Emory University)
Cited by 159
Related Papers
Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial Cells
|JNCI Journal of the National Cancer Institute|2003|257
Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
|Molecular Pharmacology|2008|158
Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation
|Proceedings of the National Academy of Sciences|2007|144
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
|Journal of Biological Chemistry|2010|98